RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Hansoh Pharmaceutical Group Company Stock

Hansoh Pharmaceutical Group Company Equity 2024

Hansoh Pharmaceutical Group Company Equity

25.79 B CNY

Ticker

3692.HK

ISIN

KYG549581067

WKN

A2PLRC

In 2024, Hansoh Pharmaceutical Group Company's equity was 25.79 B CNY, a 13.9% increase from the 22.65 B CNY equity in the previous year.

Hansoh Pharmaceutical Group Company Aktienanalyse

What does Hansoh Pharmaceutical Group Company do?

The Hansoh Pharmaceutical Group Co Ltd is a leading company in the pharmaceutical industry in China. It was founded in 1995 and has its headquarters in Lianyungang, with branches in Beijing and Shanghai. The company specializes in developing and producing innovative drugs for various diseases. It invests significant resources in research and development, collaborating with renowned research institutes and universities. Hansoh has a wide range of products in areas such as oncology, anesthesia, antibiotics, anti-infectives, and cardiovascular diseases. It has expanded its research and development activities in recent years and has partnerships with other pharmaceutical companies. The company mainly sells its products to hospitals and medical facilities in China. It is committed to strong corporate governance and sustainability, and it has been recognized for its environmental initiatives. Overall, Hansoh Pharmaceutical Group Co Ltd is a major player in the Chinese pharmaceutical industry. Hansoh Pharmaceutical Group Company ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Hansoh Pharmaceutical Group Company's Equity

Hansoh Pharmaceutical Group Company's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Hansoh Pharmaceutical Group Company's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Hansoh Pharmaceutical Group Company's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Hansoh Pharmaceutical Group Company's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Hansoh Pharmaceutical Group Company’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Hansoh Pharmaceutical Group Company stock

What is the equity of Hansoh Pharmaceutical Group Company this year?

Hansoh Pharmaceutical Group Company has equity of 25.79 B CNY this year.

What was the equity of Hansoh Pharmaceutical Group Company compared to the previous year?

The equity of Hansoh Pharmaceutical Group Company has increased/decreased by 13.9% increased compared to the previous year.

What impact does a high equity have on investors of Hansoh Pharmaceutical Group Company?

A high equity is advantageous for investors of Hansoh Pharmaceutical Group Company as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Hansoh Pharmaceutical Group Company?

A low equity can be a risk for investors of Hansoh Pharmaceutical Group Company, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Hansoh Pharmaceutical Group Company affect the company?

An increase in equity of Hansoh Pharmaceutical Group Company can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Hansoh Pharmaceutical Group Company affect the company?

A reduction in equity of Hansoh Pharmaceutical Group Company can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Hansoh Pharmaceutical Group Company?

Some factors that can affect the equity of Hansoh Pharmaceutical Group Company include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Hansoh Pharmaceutical Group Company so important for investors?

The equity of Hansoh Pharmaceutical Group Company is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Hansoh Pharmaceutical Group Company take to change the equity?

To change equity, Hansoh Pharmaceutical Group Company can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Hansoh Pharmaceutical Group Company pay?

Over the past 12 months, Hansoh Pharmaceutical Group Company paid a dividend of 0.19 CNY . This corresponds to a dividend yield of about 1.15 %. For the coming 12 months, Hansoh Pharmaceutical Group Company is expected to pay a dividend of 0.2 CNY.

What is the dividend yield of Hansoh Pharmaceutical Group Company?

The current dividend yield of Hansoh Pharmaceutical Group Company is 1.15 %.

When does Hansoh Pharmaceutical Group Company pay dividends?

Hansoh Pharmaceutical Group Company pays a quarterly dividend. This is distributed in the months of October, July, October, July.

How secure is the dividend of Hansoh Pharmaceutical Group Company?

Hansoh Pharmaceutical Group Company paid dividends every year for the past 0 years.

What is the dividend of Hansoh Pharmaceutical Group Company?

For the upcoming 12 months, dividends amounting to 0.2 CNY are expected. This corresponds to a dividend yield of 1.23 %.

In which sector is Hansoh Pharmaceutical Group Company located?

Hansoh Pharmaceutical Group Company is assigned to the 'Health' sector.

Wann musste ich die Aktien von Hansoh Pharmaceutical Group Company kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hansoh Pharmaceutical Group Company from 7/17/2024 amounting to 0.142 CNY, you needed to have the stock in your portfolio before the ex-date on 6/19/2024.

When did Hansoh Pharmaceutical Group Company pay the last dividend?

The last dividend was paid out on 7/17/2024.

What was the dividend of Hansoh Pharmaceutical Group Company in the year 2023?

In the year 2023, Hansoh Pharmaceutical Group Company distributed 0.23 CNY as dividends.

In which currency does Hansoh Pharmaceutical Group Company pay out the dividend?

The dividends of Hansoh Pharmaceutical Group Company are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Hansoh Pharmaceutical Group Company

Our stock analysis for Hansoh Pharmaceutical Group Company Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hansoh Pharmaceutical Group Company Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.